Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.

Autor:	Kocheise L; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Piseddu I; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Department of Medicine II, University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany., Vonderlin J; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Tjwa ET; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Department of Gastroenterology and Hepatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Buescher G; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Meunier L; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Service Hépato-Gastro Entérologie, Hôpital St-Eloi, CHU Montpellier, Montpellier, France., Goeggelmann P; Department of Internal Medicine I, University Hospital Regensburg, Regensburg, Germany., Fianchi F; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; CEMAD-Centro Malattie dell'Apparato Digerente, Fondazione Policlinico Universitario Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy., Dumortier J; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Service d'hépato-gastroentérologie, Hôpital Edouard Herriot - Hospices civils de Lyon, Université de Lyon, Lyon, France., Barciela MR; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Liver Unit, Department of Internal Medicine, Hospital Universitari Valle d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Gevers TJG; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Department of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, Netherlands.; Nutrim School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, Netherlands., Beretta-Piccoli BT; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Epatocentro Ticino, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.; MowatLabs, Faculty of Life Sciences & Medicine, King's College London, King's College Hospital, London, United Kingdom., Londoño MC; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Liver Unit, Hospital Clinic Barcelona, FCRB-IDIBAPS, CIBEREHD, University of Barcelona, Barcelona, Spain., Frankova S; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czechia., Roesner T; Department of Medical Oncology, National Center of Tumor Diseases (NCT) Heidelberg and Universitätsklinikum Heidelberg, Heidelberg, Germany., Joerg V; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Schmidt C; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Glaser F; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Sutter JP; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Fründt TW; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Lohse AW; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Huber S; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., von Felden J; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Sebode M; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Schulze K; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.
Jazyk:	angličtina
Zdroj:	Frontiers in immunology [Front Immunol] 2024 Jan 24; Vol. 15, pp. 1369747. Date of Electronic Publication: 2024 Jan 24 (Print Publication: 2024).
DOI:	10.3389/fimmu.2024.1369747
Abstrakt:	[This corrects the article DOI: 10.3389/fimmu.2023.1326078.]. (Copyright © 2024 Kocheise, Piseddu, Vonderlin, Tjwa, Buescher, Meunier, Goeggelmann, Fianchi, Dumortier, Barciela, Gevers, Beretta-Piccoli, Londoño, Frankova, Roesner, Joerg, Schmidt, Glaser, Sutter, Fründt, Lohse, Huber, von Felden, Sebode and Schulze.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu